市场调查报告书
商品编码
1494603
胃肠道设备市场:按产品、适应症和最终用户划分 - 全球预测 2024-2030Gastrointestinal Devices Market by Product, Indication, End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
胃肠道设备市场规模预计2023年为75.4亿美元,预计2024年将达到81.1亿美元,2030年将达到126.5亿美元,复合年增长率为7.67%。
胃肠道设备是用于诊断、治疗和管理胃肠道和消化器官系统疾病的医疗设备。包括内视镜、切片检查装置、支架及肠道餵食帮浦等设备。随着世界人口老化,大肠直肠癌、胃食道逆流(GERD)等常见影响老年人的胃肠道疾病数量不断增加,诊断和治疗的需求不断增加。随着越来越多的政府和个人优先考虑医疗保健,医疗保健基础设施(包括先进的医疗设备)的投资和资金筹措不断增加,以实现更好的疾病管理。然而,胃肠道设备,尤其是那些技术先进的胃肠道设备,操作起来可能很复杂,需要大量的培训和专业知识,并且并非在所有医疗机构中都容易获得。适当的维护和严格的灭菌通讯协定对于避免感染并确保病人和医护人员的安全至关重要,任何疏忽都可能导致严重的健康风险。人工智慧和机器学习的结合可以提高胃肠设备的诊断能力,从而实现更准确、更有效率的患者照护。开发提供更强连接和远端监控功能的设备来帮助管理慢性胃肠道疾病可以改善患者的治疗效果并减少就诊次数。
主要市场统计 | |
---|---|
基准年[2023] | 75.4亿美元 |
预测年份 [2024] | 81.1亿美元 |
预测年份 [2030] | 126.5亿美元 |
复合年增长率(%) | 7.67% |
区域洞察
以美国和加拿大为中心的美洲地区由于其先进的医疗基础设施和主要设备製造商的强大影响力,代表了胃肠道设备的强劲市场环境。美洲消费者的需求是由对微创手术的偏好所驱动的,这种手术可以提供更快的恢復时间和更短的住院时间。该地区最近的专利专注于提高诊断能力和患者舒适度,包括创新的内视镜摄影机和新的支架材料。投资正在积极进行,并正在进行研究以开发更精确、侵入性更小的技术。欧盟国家代表着一个多元化的市场,广泛接受先进的医疗技术,并拥有强调病人安全和有效性的强有力的法规结构。这里的重点是改善老龄化社会的生活质量,导致结肠镜和胶囊内视镜等胃肠设备的持续引入。欧盟透过「地平线欧洲」等框架积极促进医疗保健研究,特别是促进个人化医疗和非侵入性治疗的创新。由于政府旨在提供全面健康保险和促进本地製造的医疗改革,亚太地区的胃肠道设备市场正在迅速扩大。消费者正在接受新的胃肠道治疗技术。地方创新得到大规模、国家资助的研究计画的支持,旨在开发更便宜的诊断设备和治疗方法。
FPNV定位矩阵
FPNV 定位矩阵对于评估胃肠道设备市场供应商的市场定位至关重要。此矩阵提供了对供应商的全面评估,并检查了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对胃肠道设备市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该行业竞争力的宝贵见解,包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在胃肠道设备市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[195 Pages Report] The Gastrointestinal Devices Market size was estimated at USD 7.54 billion in 2023 and expected to reach USD 8.11 billion in 2024, at a CAGR 7.67% to reach USD 12.65 billion by 2030.
Gastrointestinal devices are medical tools used to diagnose, treat, and manage disorders of the gastrointestinal tract and digestive system. These include a range of instruments such as endoscopes, biopsy devices, stents, and enteral feeding pumps. As the global population ages, there is an increase in gastrointestinal conditions that typically affect older adults, such as colorectal cancer and gastroesophageal reflux disease (GERD), driving the need for diagnostic and therapeutic gastrointestinal devices. As more governments and individuals prioritize healthcare, there is increased investment and funding in healthcare infrastructures, including advanced medical devices, for better disease management. However, gastrointestinal devices, especially those that are technologically advanced, can be complex to operate, requiring extensive training and expertise, which might not be readily available in all healthcare settings. Proper maintenance and strict sterilization protocols are critical to avoid infections and ensure the safety of both patients and healthcare providers, and any lapses can lead to serious health risks. Incorporating artificial intelligence and machine learning can enhance the diagnostic capabilities of gastrointestinal devices, leading to more precise and efficient patient care. Developing devices that offer better connectivity and remote monitoring capabilities to assist in the management of chronic gastrointestinal conditions can improve patient outcomes and reduce hospital visits.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 7.54 billion |
Estimated Year [2024] | USD 8.11 billion |
Forecast Year [2030] | USD 12.65 billion |
CAGR (%) | 7.67% |
Regional Insights
The Americas region, particularly the U.S. and Canada, represents a robust landscape for gastrointestinal devices due to its advanced healthcare infrastructure and strong presence of major device manufacturers. Consumer needs in the Americas region are driven by the preference for minimally invasive procedures offering quicker recovery times and reduced hospital stays. Recent patents in the region have focused on improving diagnostic capabilities and patient comfort, such as innovative endoscopic cameras and new materials for stents. Investments are robust, often channeled into research for developing more precise and less invasive technologies. EU countries exhibit a diverse market with widespread acceptance of advanced medical technologies due to strong regulatory frameworks that emphasize patient safety and efficacy. The focus here is on enhancing the quality of life of the aging population, leading to a sustained adoption of gastrointestinal devices such as colonoscopes and capsule endoscopy devices. The EU's active promotion of healthcare research through frameworks such as Horizon Europe fosters innovation, particularly in personalized medicine and non-invasive treatments. APAC's market for gastrointestinal devices is rapidly expanding due to robust governmental health reforms aimed at providing comprehensive health insurance coverage and boosting local manufacturing. Consumers are increasingly accepting new gastrointestinal treatment technologies. Local innovation is supported by significant state-funded research initiatives aimed at developing less costly diagnostic devices and treatments.
Market Insights
The market dynamics represent an ever-changing landscape of the Gastrointestinal Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Gastrointestinal Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Gastrointestinal Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Fujifilm Introduces Tracmotion ESD Device at Endocon 2024
Fujifilm unveiled its newest endoscopic device, Tracmotion, at Endocon 2024 in Delhi, a key event in gastroenterology advancements. Tracmotion, which has received the red dot award, enhances the endoscopic submucosal dissection (ESD) process, a vital, minimally invasive procedure used to remove precancerous and cancerous lesions in the gastrointestinal tract. The device enables a more precise and effective treatment by allowing surgeons to target and remove lesions while preserving healthy tissue, thereby facilitating early intervention in gastrointestinal diseases. [Published On: 2024-04-23]
FDA Grants De Novo Clearance to AnX Robotica's AI-assisted Endoscopy Tool, NaviCam ProScan
AnX Robotica, a U.S.-based manufacturing firm, has obtained de novo clearance from the FDA for its innovative tool, NaviCam ProScan. This advanced AI-assisted endoscopy device leverages convolutional neural networks (CNNs) to enhance diagnostic capabilities. Specifically, it employs deep learning to distinguish between healthy tissue and abnormal lesions during endoscopic procedures, promising significant improvements in the accuracy and efficiency of gastrointestinal diagnosis. [Published On: 2024-01-03]
Medtronic and Cosmo Amplify AI-Driven Endoscopy Collaboration with Expanded Partnership
Medtronic has committed USD 100 million upfront to enhance its exclusive global distribution agreement with Cosmo Intelligent Medical Devices, focusing on the GI Genius platform. GI Genius, which obtained de novo clearance in 2021, integrates machine learning to assist in identifying potential lesions during colonoscopies by marking areas of interest, aiding physicians in spotting polyps or suspected tumors more effectively. This extension of the collaboration underscores the integration of advanced technology in gastrointestinal diagnostics and the commitment to improving detection capabilities. [Published On: 2023-12-11]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Gastrointestinal Devices Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Gastrointestinal Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Asahi Kasei Medical Co., Ltd., Becton, Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Getinge AB, Johnson & Johnson Services, Inc., Karl Storz SE & Co. KG, Leo Medical Co.,Ltd., Medtronic plc, Merit Medical Systems, Inc., Micro-Tech (Nanjing) Co., Ltd., Olympus Corporation, Ovesco Endoscopy AG, Pentax Medical by HOYA Corporation, Prion Medical BV, Richard Wolf GmbH, Siemens Healthineers AG, Smith+Nephew, STERIS Corporation, Stryker Corporation, Teleflex Incorporated, and W. L. Gore & Associates, Inc..
Market Segmentation & Coverage